EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Immunotherapy as a treatment for Stroke: Utilizing regulatory T cells

Yuanwei Li, Devin W. McBride, Yingxin Tang, Desislava Doycheva, John H. Zhang, Zhouping Tang

Brain Hemorrhages · 2023-09 · 4 (3) · 147-153

DOI: 10.1016/j.hest.2023.02.003 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Brain Hemorrhages, 2023-09. Verfasst von Yuanwei Li und 5 weiteren Autor:innen. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 97 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, Key Research and Development Program of Hunan Province of China.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Förderung

  • National Natural Science Foundation of China
  • Key Research and Development Program of Hunan Province of China

Zitieren

APA

Li, Y., McBride, D. W., Tang, Y., Doycheva, D., Zhang, J. H., & Tang, Z. (2023). Immunotherapy as a treatment for Stroke: Utilizing regulatory T cells. Brain Hemorrhages, 4(3), 147-153. https://doi.org/10.1016/j.hest.2023.02.003

Vancouver

Li Y, McBride DW, Tang Y, Doycheva D, Zhang JH, Tang Z. Immunotherapy as a treatment for Stroke: Utilizing regulatory T cells. Brain Hemorrhages. 2023;4(3):147-153. doi:10.1016/j.hest.2023.02.003

BibTeX
@article{Li2023,
  author = {Li, Yuanwei and McBride, Devin W. and Tang, Yingxin and Doycheva, Desislava and Zhang, John H. and Tang, Zhouping},
  title = {Immunotherapy as a treatment for Stroke: Utilizing regulatory T cells},
  journal = {Brain Hemorrhages},
  year = {2023},
  volume = {4},
  number = {3},
  pages = {147--153},
  doi = {10.1016/j.hest.2023.02.003}
}
Kostenlos starten →